Protalix BioTherapeutics (PLX) Revenue (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 269.98% |
| Dec 31, 2025 | -48.90% |
| Sep 30, 2025 | 14.01% |
| Jun 30, 2025 | 54.83% |
| Mar 31, 2025 | -44.49% |
| Dec 31, 2024 | 1.44% |
| Sep 30, 2024 | 33.29% |
| Jun 30, 2024 | 259.50% |
| Mar 31, 2024 | -64.26% |
| Dec 31, 2023 | 1.36% |
| Sep 30, 2023 | -70.51% |
| Jun 30, 2023 | 265.82% |
| Mar 31, 2023 | 11.27% |
| Dec 31, 2022 | -39.24% |
| Sep 30, 2022 | 62.04% |
| Jun 30, 2022 | -45.58% |
| Mar 31, 2022 | 88.15% |
| Dec 31, 2021 | -29.08% |
| Sep 30, 2021 | 87.55% |
| Jun 30, 2021 | -43.22% |
| Mar 31, 2021 | -41.93% |
| Dec 31, 2020 | 80.68% |
| Sep 30, 2020 | -1.61% |
| Jun 30, 2020 | -49.33% |
| Mar 31, 2020 | 54.85% |
| Dec 31, 2019 | -1.89% |
| Sep 30, 2019 | 16.34% |
| Jun 30, 2019 | 17.32% |
| Mar 31, 2019 | 494.48% |
| Dec 31, 2018 | 164.86% |
| Sep 30, 2018 | -66.95% |
| Jun 30, 2018 | -55.94% |
| Mar 31, 2018 | 152.94% |
| Dec 31, 2017 | -76.08% |
| Sep 30, 2017 | 18.37% |
| Jun 30, 2017 | 286.27% |
| Mar 31, 2017 | -20.90% |
| Dec 31, 2016 | -55.44% |
| Sep 30, 2016 | 163.99% |
| Jun 30, 2016 | 160.53% |
| Sep 30, 2015 | 0.00% |
| Jun 30, 2015 | -21.04% |
| Mar 31, 2014 | 182.50% |
| Dec 31, 2013 | -455.34% |
| Sep 30, 2013 | 0.88% |
| Jun 30, 2013 | -36.55% |
| Mar 31, 2013 | 204.44% |
| Dec 31, 2012 | -68.53% |
| Sep 30, 2012 | -85.74% |
| Jun 30, 2012 | 576.33% |
| Mar 31, 2012 | 63.46% |
| Dec 31, 2011 | 108.66% |
| Sep 30, 2011 | 48.17% |
| Jun 30, 2011 | -81.49% |
| Mar 31, 2011 | 251.02% |
| Dec 31, 2010 | -63.07% |
| Sep 30, 2010 | 179.05% |